Facilitation of drug evaluation in children by population methods and modelling
M Tod, V Jullien, G Pons - Clinical pharmacokinetics, 2008 - Springer
The pharmacokinetics and pharmacodynamics of drugs are different in adult and paediatric
populations, the latter being particularly heterogeneous. These differences in …
populations, the latter being particularly heterogeneous. These differences in …
Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates
M Wilbaux, A Fuchs, J Samardzic… - The Journal of …, 2016 - Wiley Online Library
Sepsis remains a major cause of mortality and morbidity in neonates, and, as a
consequence, antibiotics are the most frequently prescribed drugs in this vulnerable patient …
consequence, antibiotics are the most frequently prescribed drugs in this vulnerable patient …
[图书][B] Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, -Three Volume Set
Kucers' The Use of Antibiotics is the definitive, internationally-authored reference, providing
everything that the infectious diseases specialist and prescriber needs to know about …
everything that the infectious diseases specialist and prescriber needs to know about …
Developmental pharmacokinetics of antibiotics used in neonatal ICU: focus on preterm infants
OI Butranova, EA Ushkalova, SK Zyryanov… - Biomedicines, 2023 - mdpi.com
Neonatal Infections are among the most common reasons for admission to the intensive
care unit. Neonatal sepsis (NS) significantly contributes to mortality rates. Empiric antibiotic …
care unit. Neonatal sepsis (NS) significantly contributes to mortality rates. Empiric antibiotic …
Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling
PJ De Sutter, P Rossignol, L Breëns, E Gasthuys… - Pharmaceutics, 2023 - mdpi.com
The volume of distribution at steady state (Vss) in neonates is still often estimated through
isometric scaling from adult values, disregarding developmental changes beyond body …
isometric scaling from adult values, disregarding developmental changes beyond body …
Population pharmacokinetic analysis during the first 2 years of life: an overview
A Marsot, A Boulamery, B Bruguerolle… - Clinical pharmacokinetics, 2012 - Springer
Three decades after its introduction, pharmacokinetic population approaches have become
a reference method for drug modelling, particularly in paediatrics. The main practical …
a reference method for drug modelling, particularly in paediatrics. The main practical …
Optimization of β-Lactam Dosing Regimens in Neonatal Infections: Continuous and Extended Administration versus Intermittent Administration
E Leegwater, L Wewerinke, AM de Grauw… - Clinical …, 2023 - Springer
Abstract Background and Objective In neonates, β-Lactam antibiotics are almost exclusively
administered by intermittent infusion. However, continuous or prolonged infusion may be …
administered by intermittent infusion. However, continuous or prolonged infusion may be …
[HTML][HTML] Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology
CIS Barker, E Germovsek, RL Hoare, JM Lestner… - Advanced drug delivery …, 2014 - Elsevier
Pharmacokinetic/pharmacodynamic (PKPD) modelling is used to describe and quantify
dose–concentration–effect relationships. Within paediatric studies in infectious diseases and …
dose–concentration–effect relationships. Within paediatric studies in infectious diseases and …
Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates
RFW De Cock, A Smits, K Allegaert… - Journal of …, 2014 - academic.oup.com
Objectives Cefazolin is frequently administered for antimicrobial prophylaxis and treatment
of infections. In neonates, pharmacokinetic observations are limited and dosing regimens …
of infections. In neonates, pharmacokinetic observations are limited and dosing regimens …
Pharmacokinetic studies in infants using minimal-risk study designs
J Autmizguine, P Brian Smith… - Current clinical …, 2014 - ingentaconnect.com
Infants are therapeutic orphans. Many drugs used in infants are used “off-label”, increasing
the risk of drug toxicity and suboptimal efficacy in this vulnerable population. This knowledge …
the risk of drug toxicity and suboptimal efficacy in this vulnerable population. This knowledge …